Normal CD4+ T cells were more sensitive to cytotoxic compounds than cancer cells, as demonstrated by the MTT test (Figure 1), TUNEL assay (Figure 2), and the measurement of live, apoptotic, and dead cells by flow cytometry (Figure 2). The gene discussed is CD4; the disease is cancer.